Infections in solid-organ transplant recipients

R Patel, CV Paya - Clinical microbiology reviews, 1997 - Am Soc Microbiol
Solid-organ transplantation is a therapeutic option for many human diseases. Infections are
a major complication of solid-organ transplantation. All candidates should undergo a …

Gastrointestinal cytomegalovirus disease

RW Goodgame - Annals of internal medicine, 1993 - acpjournals.org
Objective: To describe the pathogenesis of gastrointestinal cytomegalovirus (CMV) disease,
the types and locations of gastrointestinal lesions, the clinical settings in which they occur …

[图书][B] Fields' virology

BN Fields - 2007 - books.google.com
Established for 20 years as the definitive virology reference, the two-volume classic Fields
Virology is in its thoroughly revised, updated Fifth Edition. More than 100 world-renowned …

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

JM Goodrich, RA Bowden, L Fisher… - Annals of internal …, 1993 - acpjournals.org
Objective: To study the efficacy and toxicity of ganciclovir prophylaxis given at engraftment to
cytomegalovirus (CMV)-seropositive, allogeneic bone marrow transplant recipients. Design …

Ganciclovir

CS Crumpacker - New England Journal of Medicine, 1996 - Mass Medical Soc
Ganciclovir is a nucleoside analogue of guanosine, a homologue of acyclovir, and the first
antiviral drug to be effective in the treatment of cytomegalovirus (CMV) disease in humans. 1 …

Ganciclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

D Faulds, RC Heel - Drugs, 1990 - Springer
Synopsis Ganciclovir is a nucleoside analogue with antiviral activity in vitro against
members of the herpes group and some other DNA viruses. It has demonstrated efficacy …

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients: results of a placebo-controlled, double-blind trial

DJ Winston, WG Ho, K Bartoni, C Du Mond… - Annals of internal …, 1993 - acpjournals.org
Objective: To evaluate the efficacy and safety of ganciclovir for prevention of
cytomegalovirus (CMV) infection and disease. Design: A randomized, placebo-controlled …

Ocular manifestations of HIV infection.

DA Jabs - Transactions of the American Ophthalmological Society, 1995 - ncbi.nlm.nih.gov
OBJECTIVE: To evaluate the frequency of ocular complications and the clinical outcomes of
these complications in patients with various stages of HIV infection. METHODS …

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

IG Sia, R Patel - Clinical microbiology reviews, 2000 - Am Soc Microbiol
In the past three decades since the inception of human organ transplantation,
cytomegalovirus (CMV) has gained increasing clinical import because it is a common …

Current antivirals and novel botanical molecules interfering with herpes simplex virus infection

DM Álvarez, E Castillo, LF Duarte, J Arriagada… - Frontiers in …, 2020 - frontiersin.org
Herpes simplex viruses type 1 (HSV-1) and type 2 (HSV-2) are highly prevalent within the
human population and are characterized by lifelong infections and sporadic recurrences …